miR-222 Cancer Research Results
miR-222, miR-222: Click to Expand ⟱
| Source: |
| Type: |
miR-222 (the sister miRNA of miR-221) is a context-dependent but predominantly oncogenic microRNA (oncomiR). It drives cell-cycle progression, EMT, invasion, immune evasion, and therapy resistance in many solid tumors
-In Cancer: frequently upregulated in aggressive tumors
|
Scientific Papers found: Click to Expand⟱
Apoptosis↑, TumCCA↑, Let-7↑, miR-34b-5p↑, miR-122-5p↑, miR-126↑, miR-195↑, miR-199↑, miR-206↑, miR-326-5p↑, Hif1a↓, PI3K↓, cMyc↓, AMPK↑, P53↑, Glycolysis↓, HK2↓, LDHA↓, PKM2↓, PPP↓, G6PD↓, GlutaM↓, GLS↓, miR-21↑, miR-221↑, miR-222↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
miR-122-5p↑, 1, miR-195↑, 1, miR-199↑, 1, miR-326-5p↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, cMyc↓, 1, G6PD↓, 1, GLS↓, 1, GlutaM↓, 1, Glycolysis↓, 1, HK2↓, 1, LDHA↓, 1, PKM2↓, 1, PPP↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
miR-21↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Let-7↑, 1, PI3K↓, 1,
Migration(tgid=13) ⓘ
miR-206↑, 1, miR-221↑, 1, miR-222↑, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 1, miR-126↑, 1, miR-34b-5p↑, 1,
Total Targets: 26
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: miR-222, miR-222
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1399 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page